IReP - Imagery Rescripting as a treatment for Prolonged Grief Disorder

IReP - Imagery Rescripting as a treatment for Prolonged Grief Disorder - IReP

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00027855

Enrollment

Registered

2022-02-15

Start date

2023-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged Grief Disorder

Interventions

Group 1: Treatment with Imagery Rescripting, 13-15 treatment sessions of 100 minutes Group 2: Waitlist-Control-Group, 6-month waiting period

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. primary diagnosis of PGD according to I-PGD-11 2. age at least 18 years 3. willingness and readiness for grief-focused treatment 4. MMSE>25 5. signed informed consent

Exclusion criteria

Exclusion criteria: 1. life-time psychosis or bipolar disorder as assessed with the SCID 2. acute suicide risk or risk of harm of others 3. substance dependence as assessed with the SCID 4. start of new medication within one month prior to the study 5. ongoing or planned psychotherapy or a psychosomatic rehabilitation within the duration of the study

Design outcomes

Primary

Measure	Time frame
remission rate (percentage of patients no longer meeting the PGD-diagnosis according to I-PGD-11 at post-assessment)	—

Secondary

Measure	Time frame
change in PGD symptom-severity (I-PGD-11 number of symptoms, self-reported symptoms according to IPGDS), change in BSI, BDI-II, SOMS-7T, MIQ	—

Countries

Germany

Contacts

Public ContactMirjam Sophie Rüger

Goethe-Universität Frankfurt, Zentrum für Psychotherapie Verhaltenstherapieambulanz

irep@zpt-gu.de06979823973

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026